Seeing Is Believing
LTRN is currently covered by 1 analysts with an average price target of $9.57. This is a potential upside of $6 (168.07%) from yesterday's end of day stock price of $3.57.
Lantern Pharma's activity chart (see below) currently has 1 price targets and 8 ratings on display. The stock rating distribution of LTRN is 80% BUY and 20% HOLD.
Highest price target for LTRN is $5, Lowest price target is $4, average price target is $11.
Most recent stock forecast was given by MICHAEL KING from HCWAINWRIGHT on 10-Aug-2023. First documented stock forecast 07-Oct-2021.
Currently out of the existing stock ratings of LTRN, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$7.34 (200.55%)
$11
1 years 7 months 1 days ago
(10-Aug-2023)
0/5 (0%)
$6 (120.00%)
What is LTRN (Lantern Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on LTRN (Lantern Pharma) with a proven track record?
Which analyst has the most public recommendations on LTRN (Lantern Pharma)?
Which analyst is the currently most bullish on LTRN (Lantern Pharma)?